Rheumatoid Arthritis
Conditions
Keywords
High intensity exercise, cardiovascular risk factors
Brief summary
The primary aim of the study is to investigate if 10 weeks of high intensity interval training improve inflammatory status in patients with rheumatoid arthritis.
Detailed description
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks synovial joints. Although the cause of rheumatoid arthritis is unknown, autoimmunity plays a role in both the chronicity and progression, and RA is considered as a systemic autoimmune disease. Due to chronic inflammatory status, RA-patients are at higher risk of developing cardiovascular disease (CVD) compared to the general population. Accumulating evidence indicates that regular physical activity has beneficial effects on RA. The mechanisms behind exercise-induce improvements are none the less unclear and more research is needed to better understand the beneficial effects of exercise training in this patient group. Recently, promising results from gene expression studies of blood cells have revealed unexplored fields of biomarker discovery and gene expression profiling of disease. Due to easy accessible and minimally invasive sample collection, gene expression profiling of whole blood might turn out to be a promising tool in molecular diagnostics and clinical medicine. To our knowledge, whole-genome transcriptional changes have not previously been studied in RA-patients undergoing a high-intensity exercise program. Hypothesis: Ten weeks of high intensity interval training improves the inflammatory status, quality of life, and known risk factors for cardiovascular diseases. In addition to measure traditionally inflammatory markers in the blood, whole genome analysis will be made.
Interventions
BEHAVIORALhigh intensity interval training
First 10 week of high intensity interval training, twice a week. The interval training session consists of 10 minutes warm up at 70 percent of maximal heart rate and continues with 4 times 4 minutes of high intensity intervals at 90 to 95 percent of maximal heart rate separated by 3 minutes of active brakes in between at 70 percent of maximal heart rate. Training will be performed by cycling. Training intensity will be supervised through the use of polar puls monitors and the BORG scale of subjective perceived exhaustion. Second 10 weeks participants are instructed not to change their dietary patterns or physical activity levels during the study period.
BEHAVIORALControl
First 10 weeks participants are instructed not to change their dietary patterns or physical activity levels, and to continue their habitually lifestyle. Second 10 week of high intensity interval training, twice a week. The interval training session consists of 10 minutes warm up at 70 percent of maximal heart rate and continues with 4 times 4 minutes of high intensity intervals at 90 to 95 percent of maximal heart rate separated by 3 minutes of active brakes in between at 70 percent of maximal heart rate. Training will be performed by cycling. Training intensity will be supervised through the use of polar puls monitors and the BORG scale of subjective perceived exhaustion.
Sponsors
Norwegian University of Science and Technology
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Ability to exercise * written consent
Exclusion criteria
* Inability to exercise * Known ischemic cardiovascular disease * Severe pulmonary disease * High activity level * Pregnancy * drug/alcohol abuse * Unstable RA * diagnosis before 2000
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Inflammatory markers in blood | 10 weeks | C-reactive Protein (CRP), TNF-alfa, COMP, Pentraxin 3 using ELISA Whole-genome gene expression in blood cells using RNA(HumanHT-12 v4 Expression BeadChip) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| quality of life | 10 weeks | Questionnaire SF-36 |
| HDL | 10 weeks | Standard biochemical analysis procedure at St.Olavs hospital |
| Endothelial function | 10 weeks | Flow mediated dilatation (FMD). |
| Blood glucose | 10 weeks | Standard biochemical analysis procedure at St.Olavs hospital |
| whole-genome gene expression in blood cells | 10 weeks | total RNA isolated from whole blood (Qiagen, Bioanalyzer, NanoDrop). Gene expression analysis on HumanHT-12 v4 Expression BeadChip. |
| Total Cholesterol | 10 weeks | Standard biochemical analysis procedure at St.Olavs hospital |
Countries
Norway
Outcome results
None listed